AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

RecruitingNAAges 18 Years - anyAllClinical Hospital Center, Split
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Rhegmatogenous Retinal Detachment is a pathological condition in which the inner layers of the retina separate from its outermost layer due to fluid entering between these layers through a retinal tear. Retinal detachment is one of the most urgent conditions in ophthalmology; if left untreated, it leads to severe vision loss and blindness. The only possible treatment is a surgical procedure to close the tear and reattach the separated retinal layers. Currently, three techniques are used for surgically managing retinal detachment with a tear. You will undergo a technique called pneumatic retinopexy. In this procedure, reattachment of the retina is achieved by injecting sulfur hexafluoride gas (SF6) into the vitreous (the gel that fills the eye) about 4 millimeters from the corneal edge, using a very fine needle. The retinal tear is then closed by either freezing (cryotherapy) immediately

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with rhegmatogenous retinal detachment with one or more tears within two clock hours, limited to the upper half of the retina Exclusion Criteria: * Patients with tears in the lower half of the retina * Patients with multiple retinal tears covering more than two clock hours * Patients with developed proliferative vitreoretinopathy * Patients with vitreous hemorrhage * Patients with opaque optical media due to other conditions that could obstruct a detailed fundus examination or the procedure itself * Patients unable to follow postoperative head positioning instructions * Patients under age of 18 years
๐Ÿ’Š

What it tests

  • Pneumatic retinopexy with transscleral cryopexy
  • Pneumatic retinopexy with laser photocoagulation
๐Ÿ“

Where

1 site
Clinical Hospital Center, Split
Split, Croatia
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy